These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33968738)

  • 1. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
    He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
    Front Oncol; 2021; 11():639600. PubMed ID: 33968738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
    Fei H; Chen S; Xu C
    Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma.
    Luo X; Feng L; Xu W; Bai X; Wu M
    Evol Bioinform Online; 2021; 17():11769343211009898. PubMed ID: 33911849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
    Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
    Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
    Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
    Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics Identification of Key Genes for the Development and Prognosis of Lung Adenocarcinoma.
    Luo X; Xu JG; Wang Z; Wang X; Zhu Q; Zhao J; Bian L
    Inquiry; 2022; 59():469580221096259. PubMed ID: 35635202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
    Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
    Front Genet; 2020; 11():547. PubMed ID: 32595698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
    Deng H; Hang Q; Shen D; Zhang Y; Chen M
    Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of differentially expressed genes in tumor and paracancerous tissues of patients with lung adenocarcinoma.
    Yang R; Zhou Y; Du C; Wu Y
    J Thorac Dis; 2020 Dec; 12(12):7355-7364. PubMed ID: 33447425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma.
    Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L
    Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential biomarkers for lung adenocarcinoma: a study based on bioinformatics analysis combined with validation experiments.
    Zhang C; Liu Y; Lu Y; Chen Z; Liu Y; Mao Q; Bao S; Zhang G; Zhang Y; Lin H; Li H
    Front Oncol; 2024; 14():1425895. PubMed ID: 39364312
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.
    Yi X; Luo L; Zhu Y; Deng H; Liao H; Shen Y; Zheng Y
    Cancer Cell Int; 2022 Oct; 22(1):324. PubMed ID: 36266702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.
    Zhao C; Liu J; Zhou H; Qian X; Sun H; Chen X; Zheng M; Bian T; Liu L; Liu Y; Zhang J
    Cancer Cell Int; 2021 Apr; 21(1):228. PubMed ID: 33879165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis.
    Guo Q; Ke XX; Liu Z; Gao WL; Fang SX; Chen C; Song YX; Han H; Lu HL; Xu G
    Front Genet; 2020; 11():242. PubMed ID: 32265985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways.
    Zhang J; Wang X; Song C; Li Q
    BMC Cancer; 2023 Feb; 23(1):152. PubMed ID: 36782138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-SMC condensin I complex subunit H (NCAPH), a regulator of cell cycle, predicts poor prognosis in lung adenocarcinoma patients: a study mainly based on TCGA and GEO database.
    Zhou W; Hu J; Zhao J
    Transl Cancer Res; 2020 Dec; 9(12):7572-7587. PubMed ID: 35117357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma.
    Chen S; Lu Z; Chen X; Wu X; Tu H; Yu L; Xiao Z
    Oncol Lett; 2020 Nov; 20(5):147. PubMed ID: 32934715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.